{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:52:54Z","timestamp":1774565574218,"version":"3.50.1"},"reference-count":230,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    The tumor microenvironment (TME) represents a complex system comprising various cells and extracellular matrix components that play a crucial role in tumor initiation and progression. While recent therapeutic strategies for predominantly focus on targeting tumor cells, their impact on other cellular components in the TME, such as regulatory T (Treg) cells, remains insufficiently understood. The cellular components of the TME include tumor cells, immune cells, tumor-associated stromal cells, and myeloid-derived suppressor cells. Notably, the role of Treg cells in tumor therapy has emerged as a significant research area of focus in recent years. Regulatory CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells, characterized by the expression of the transcription factor Forkhead Box P3 (FOXP3) and the surface marker CD25, are pivotal in mediating immune suppression and maintaining immune tolerance and homeostasis. Current tumor treatments mainly rely on radiation and chemotherapy. Although innovative therapies such as immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T-cell (CAR-T) therapies have demonstrated promising outcomes, their efficacy is limited, benefiting only a small subset of patients. Epigenetic inhibitors are increasingly recognized as pivotal in cancer treatment; however, prior research has predominantly concentrated on their effects on the tumor itself, while overlooking the potential influence of these compounds on regulatory T cells (Tregs) within the tumor microenvironment (TME). The therapeutic viability of modulating Tregs within the TME remains uncertain. The intricate microenvironment of the TME significantly influences the distinct epigenetic landscape of tumor-infiltrating Treg cells, including modifications in DNA methylation, histone modifications, and chromatin remodeling. A comprehensive understanding of these epigenetic modifications and the underlying factors driving them could unveil novel strategies for cancer therapy. This approach would enhance the understanding of the critical role of Tregs in tumor therapy and facilitate the development of more effective targeted therapies by addressing the unique epigenetic characteristics of tumor-infiltrating Tregs.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2026.1787421","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:10:19Z","timestamp":1774563019000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor microenvironment-induced epigenetic reprogramming of Tregs and its impact on immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Wenhao","family":"Li","sequence":"first","affiliation":[{"name":"Laboratory of Epigenetics and Immunology, West China Institute of Women and Children\u2019s Health, NHC Key Laboratory of Chronobiology, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Children\u2019s medicine Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Tong","sequence":"additional","affiliation":[{"name":"Laboratory of Epigenetics and Immunology, West China Institute of Women and Children\u2019s Health, NHC Key Laboratory of Chronobiology, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Children\u2019s medicine Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-16-1020","article-title":"Synergistic immunostimulatory effects and therapeutic benefit of combined histone deacetylase and bromodomain inhibition in non-small cell lung cancer","volume":"7","author":"Adeegbe","year":"2017","journal-title":"Cancer Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41590-020-0801-7","article-title":"PD-1+ Treg cells: a foe in cancer immunotherapy?","volume":"21","author":"Aksoylar","year":"2020","journal-title":"Nat. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1172\/JCI124725","article-title":"microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance","volume":"129","author":"Anandagoda","year":"2019","journal-title":"J. Clin. Investigation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 Reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2018.02.010","article-title":"Fc effector function contributes to the activity of human Anti-CTLA-4 antibodies","volume":"33","author":"Arce Vargas","year":"2018","journal-title":"Cancer Cell."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2042065","DOI":"10.1080\/2162402X.2022.2042065","article-title":"Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with Oxaliplatin promotes robust anti-tumor response in non-small cell lung cancer","volume":"11","author":"Bag","year":"2022","journal-title":"Oncoimmunology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1101433","DOI":"10.3389\/fimmu.2023.1101433","article-title":"Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells","volume":"14","author":"Barbieri","year":"2023","journal-title":"Front. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1002\/eji.200737594","article-title":"DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells","volume":"37","author":"Baron","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1056\/NEJMra1805035","article-title":"Epigenetic therapies for cancer","volume":"383","author":"Bates","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells","volume":"20","author":"Berod","year":"2014","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ni.3660","article-title":"Epigenetic orchestration of thymic Treg cell development","volume":"18","author":"Beyer","year":"2017","journal-title":"Nat. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e004668","DOI":"10.1136\/jitc-2022-004668","article-title":"Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma","volume":"10","author":"Bhave","year":"2022","journal-title":"J. For Immunother. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1082055","DOI":"10.3389\/fimmu.2022.1082055","article-title":"Stepwise acquisition of unique epigenetic signatures during differentiation of tissue Treg cells","volume":"13","author":"Braband","year":"2022","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell. Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.redox.2015.09.028","article-title":"Macrophage polarization in the tumor microenvironment","volume":"5","author":"Br\u00fcne","year":"2015","journal-title":"Redox Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.immuni.2018.09.014","article-title":"Antibodies to costimulatory receptor 4-1BB enhance anti-tumor immunity via T regulatory cell depletion and promotion of CD8 T cell effector function","volume":"49","author":"Buchan","year":"2018","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/s41590-024-01945-3","article-title":"An atlas of genetic effects on cellular composition of the tumor microenvironment","volume":"25","author":"Cai","year":"2024","journal-title":"Nat. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"lnad019","DOI":"10.1093\/lifemedi\/lnad019","article-title":"Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy","volume":"2","author":"Carelock","year":"2023","journal-title":"Life Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1158\/0008-5472.CAN-21-1203","article-title":"To Go or not to go?-targeting tregs traveling in tumors","volume":"81","author":"Chakraborty","year":"2021","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ni.2267","article-title":"Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells","volume":"13","author":"Chang","year":"2012","journal-title":"Nat. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.intimp.2019.03.009","article-title":"MiR-155 controls follicular Treg cell-mediated humoral autoimmune intestinal injury by inhibiting CTLA-4 expression","volume":"71","author":"Chao","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12916-023-03094-0","article-title":"A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy","volume":"21","author":"Chen","year":"2023","journal-title":"BMC Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12967-024-05518-8","article-title":"Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1038\/s41467-018-07806-6","article-title":"Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape","volume":"9","author":"Chorro","year":"2018","journal-title":"Nat. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2018.09.008","article-title":"Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): a new era in cancer active immunotherapy","volume":"194","author":"Constantinidou","year":"2019","journal-title":"Pharmacol. and Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41598-019-57294-x","article-title":"HDAC10 deletion promotes Foxp3+ T-regulatory cell function","volume":"10","author":"Dahiya","year":"2020","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-021-01464-x","article-title":"Epigenetic modulation of antitumor immunity for improved cancer immunotherapy","volume":"20","author":"Dai","year":"2021","journal-title":"Mol. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1158\/1078-0432.CCR-22-0339","article-title":"Phase IB study of GITR agonist antibody TRX518 singly and in combination with gemcitabine, pembrolizumab, or nivolumab in patients with advanced solid tumors","volume":"28","author":"Davar","year":"2022","journal-title":"Clin. Cancer Res. An Official J. Am. Assoc. For Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.immuni.2024.01.019","article-title":"Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells","volume":"57","author":"Ding","year":"2024","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41590-020-0620-x","article-title":"PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer","volume":"21","author":"Diskin","year":"2020","journal-title":"Nat. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12943-021-01450-3","article-title":"Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade","volume":"20","author":"Dixon","year":"2021","journal-title":"Mol. Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jaut.2016.07.011","article-title":"The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs","volume":"75","author":"Do\u00f1as","year":"2016","journal-title":"J. Autoimmun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e2413525","DOI":"10.1002\/advs.202413525","article-title":"FGF19-Activated hepatic stellate cells release ANGPTL4 that promotes colorectal cancer liver metastasis","volume":"12","author":"Fan","year":"2025","journal-title":"Adv. Sci. Weinheim, Baden-Wurttemberg, Ger."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cmet.2019.11.021","article-title":"Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for treg suppressive function","volume":"31","author":"Field","year":"2020","journal-title":"Cell. Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1182\/blood.2021011597","article-title":"PI3K\u03b4\/\u03b3 inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity","volume":"139","author":"Funk","year":"2022","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1111\/bph.16326","article-title":"Preclinical and translational pharmacology of afucosylated anti-CCR8 antibody for depletion of tumour-infiltrating regulatory T cells","volume":"181","author":"Gampa","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41419-019-1565-6","article-title":"Blockade of miR-142-3p promotes anti-apoptotic and suppressive function by inducing KDM6A-mediated H3K27me3 demethylation in induced regulatory T cells","volume":"10","author":"Gao","year":"2019","journal-title":"Cell. Death and Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"904418","DOI":"10.3389\/fimmu.2022.904418","article-title":"3D collagen fiber concentration regulates treg cell infiltration in triple negative breast cancer","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2350448","DOI":"10.1002\/eji.202350448","article-title":"Small molecule inhibitors targeting regulatory T cells for cancer treatment","volume":"54","author":"Garc\u00eda-D\u00edaz","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1172\/JCI76012","article-title":"Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation","volume":"125","author":"Gerriets","year":"2015","journal-title":"J. Clin. Investigation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"13014","DOI":"10.1074\/jbc.M115.708560","article-title":"Regulatory T cell modulation by CBP\/EP300 bromodomain inhibition","volume":"291","author":"Ghosh","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1038\/s41467-019-12412-1","article-title":"Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis","volume":"10","author":"Godet","year":"2019","journal-title":"Nat. Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1000083","DOI":"10.1080\/2162402X.2014.1000083","article-title":"CD4+ T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells-novel implications of CD4+ T cells in pancreatic cancer development","volume":"4","author":"Goebel","year":"2015","journal-title":"Oncoimmunology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1172\/JCI99760","article-title":"Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy","volume":"128","author":"Goswami","year":"2018","journal-title":"J. Clin. Investigation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1158\/1078-0432.CCR-13-1576","article-title":"Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients","volume":"20","author":"Govindaraj","year":"2013","journal-title":"Clin. Cancer Res. An Official J. Am. Assoc. For Cancer Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"111122","DOI":"10.1016\/j.celrep.2022.111122","article-title":"Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells","volume":"40","author":"Gu","year":"2022","journal-title":"Cell. Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ccell.2025.01.001","article-title":"Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer","volume":"43","author":"Guo","year":"2025","journal-title":"Cancer Cell."},{"key":"B57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/vaccines13020117","article-title":"A phase II study of denileukin diftitox in patients with advanced treatment refractory breast cancer","volume":"13","author":"Gwin","year":"2025","journal-title":"Vaccines"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e20232068","DOI":"10.1084\/jem.20232068","article-title":"Dynamic Foxp3-chromatin interaction controls tunable Treg cell function","volume":"221","author":"He","year":"2024","journal-title":"J. Exp. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"8344","DOI":"10.1158\/0008-5472.CAN-06-3304","article-title":"Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer","volume":"67","author":"Hinz","year":"2007","journal-title":"Cancer Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"B61","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/1078-0432.CCR-21-2781","article-title":"Mogamulizumab in combination with nivolumab in a phase I\/II study of patients with locally advanced or metastatic solid tumors","volume":"28","author":"Hong","year":"2021","journal-title":"Clin. Cancer Res. An Official J. Am. Assoc. For Cancer Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Sci. (New York, N.Y.)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41591-024-03076-6","article-title":"Duvelisib plus romidepsin in relapsed\/refractory T cell lymphomas: a phase 1b\/2a trial","volume":"30","author":"Horwitz","year":"2024","journal-title":"Nat. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/embor.2008.224","article-title":"miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA","volume":"10","author":"Huang","year":"2009","journal-title":"EMBO Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"8626","DOI":"10.1038\/s41598-017-09211-3","article-title":"Histone\/protein deacetylase 11 targeting promotes Foxp3+ Treg function","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1111\/cas.15365","article-title":"Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells","volume":"113","author":"Huang","year":"2022","journal-title":"Cancer Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"8797206","DOI":"10.1155\/2016\/8797206","article-title":"HDAC inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases","volume":"2016","author":"Hull","year":"2016","journal-title":"BioMed Res. Int."},{"key":"B68","doi-asserted-by":"publisher","first-page":"eabk0957","DOI":"10.1126\/sciimmunol.abk0957","article-title":"BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors","volume":"7","author":"Itahashi","year":"2022","journal-title":"Sci. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12967-014-0218-x","article-title":"A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes","volume":"12","author":"Jebbawi","year":"2014","journal-title":"J. Transl. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e005241","DOI":"10.1136\/jitc-2022-005241","article-title":"MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2","volume":"10","author":"Jiang","year":"2022","journal-title":"J. For Immunother. Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"B72","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1083\/jcb.200908115","article-title":"Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease","volume":"187","author":"Ju","year":"2009","journal-title":"J. Cell. Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.trecan.2023.07.015","article-title":"Modulating Treg stability to improve cancer immunotherapy","volume":"9","author":"Kang","year":"2023","journal-title":"Trends Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","article-title":"Metabolic communication in the tumour-immune microenvironment","volume":"24","author":"Kao","year":"2022","journal-title":"Nat. Cell. Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/ajh.23112","article-title":"The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients","volume":"87","author":"Kelly-Sell","year":"2012","journal-title":"Am. J. Hematol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"110981","DOI":"10.1016\/j.jinorgbio.2019.110981","article-title":"Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors","volume":"206","author":"Kenny","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"188427","DOI":"10.1016\/j.bbcan.2020.188427","article-title":"Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors","volume":"1874","author":"Kes","year":"2020","journal-title":"Biochimica Biophysica Acta. Rev. Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/s41467-021-26091-4","article-title":"CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells","volume":"12","author":"Kim","year":"2021","journal-title":"Nat. Commun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41467-024-55330-7","article-title":"Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer","volume":"16","author":"Klein","year":"2025","journal-title":"Nat. Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00262-008-0618-y","article-title":"A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells","volume":"58","author":"Kong","year":"2009","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.cell.2017.11.013","article-title":"Myc cooperates with ras by programming inflammation and immune suppression","volume":"171","author":"Kortlever","year":"2017","journal-title":"Cell."},{"key":"B83","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41556-021-00807-6","article-title":"The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin","volume":"24","author":"Krastev","year":"2022","journal-title":"Nat. Cell. Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41571-024-00870-6","article-title":"Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine","volume":"21","author":"Kumagai","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.2217\/imt-2019-0060","article-title":"Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy","volume":"11","author":"Kumar","year":"2019","journal-title":"Immunotherapy"},{"key":"B86","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","article-title":"Cytokines in cancer","volume":"43","author":"Kureshi","year":"2025","journal-title":"Cancer Cell."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1158\/2767-9764.CRC-23-0566","article-title":"Epigenetic induction of cancer-testis antigens and endogenous retroviruses at single-cell level enhances immune recognition and response in glioma","volume":"4","author":"Lai","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e8322","DOI":"10.15252\/msb.20188322","article-title":"Tumor-stroma interactions differentially alter drug sensitivity based on the origin of stromal cells","volume":"14","author":"Landry","year":"2018","journal-title":"Mol. Syst. Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ccell.2022.08.002","article-title":"Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC","volume":"40","author":"Leung","year":"2022","journal-title":"Cancer Cell."},{"key":"B90","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/sji.12367","article-title":"CCL20-CCR6 cytokine network facilitate treg activity in advanced grades and metastatic variants of hepatocellular carcinoma","volume":"83","author":"Li","year":"2016","journal-title":"Scand. J. Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1002\/eji.201041093","article-title":"Efficient Treg depletion induces T-cell infiltration and rejection of large tumors","volume":"40","author":"Li","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41419-021-04030-x","article-title":"Hypoxic stress suppresses lung tumor-secreted exosomal miR101 to activate macrophages and induce inflammation","volume":"12","author":"Li","year":"","journal-title":"Cell. Death and Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"641883","DOI":"10.3389\/fimmu.2021.641883","article-title":"Metabolites in the tumor microenvironment reprogram functions of immune effector cells through epigenetic modifications","volume":"12","author":"Li","year":"","journal-title":"Front. Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1308264","DOI":"10.3389\/fimmu.2023.1308264","article-title":"Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors","volume":"14","author":"Liang","year":"2023","journal-title":"Front. Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"103729","DOI":"10.1016\/j.cellimm.2017.12.003","article-title":"Cancer-associated fibroblasts in tumor microenvironment - accomplices in tumor malignancy","volume":"343","author":"Liao","year":"2019","journal-title":"Cell. Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e120626","DOI":"10.1172\/jci.insight.120626","article-title":"Phosphoinositide 3-kinase \u03b4 inhibition promotes antitumor responses but antagonizes checkpoint inhibitors","volume":"3","author":"Lim","year":"2018","journal-title":"JCI Insight"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e2136","DOI":"10.1002\/onco.13957","article-title":"Phase I study of entinostat in combination with enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer","volume":"26","author":"Lin","year":"2021","journal-title":"Oncol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/cgt.2011.8","article-title":"Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models","volume":"18","author":"Liu","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm.3286","article-title":"Inhibition of p300 impairs Foxp3+ T regulatory cell function and promotes antitumor immunity","volume":"19","author":"Liu","year":"2013","journal-title":"Nat. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1158\/0008-5472.CAN-14-2108","article-title":"FOXP3 controls an miR-146\/NF-\u03baB negative feedback loop that inhibits apoptosis in breast cancer cells","volume":"75","author":"Liu","year":"2015","journal-title":"Cancer Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.immuni.2019.06.017","article-title":"Treg cells promote the SREBP1-Dependent metabolic fitness of tumor-promoting macrophages via repression of CD8+ T cell-derived Interferon-\u03b3","volume":"51","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1746573","DOI":"10.1080\/2162402X.2020.1746573","article-title":"Heterogeneity of exhausted T cells in the tumor microenvironment is linked to patient survival following resection in hepatocellular carcinoma","volume":"9","author":"Liu","year":"2020","journal-title":"Oncoimmunology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.it.2021.12.004","article-title":"Tumor microenvironment metabolites directing T cell differentiation and function","volume":"43","author":"Liu","year":"2022","journal-title":"Trends Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41467-023-44391-9","article-title":"FOXP3+ regulatory T cell perturbation mediated by the IFN\u03b3-STAT1-IFITM3 feedback loop is essential for anti-tumor immunity","volume":"15","author":"Liu","year":"","journal-title":"Nat. Commun."},{"key":"B106","doi-asserted-by":"publisher","first-page":"eadi7764","DOI":"10.1126\/sciadv.adi7764","article-title":"Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy","volume":"10","author":"Liu","year":"","journal-title":"Sci. Adv."},{"key":"B107","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/biom15010071","article-title":"Epigenetic regulation of stromal and immune cells and therapeutic targets in the tumor microenvironment","volume":"15","author":"Liu","year":"","journal-title":"Biomolecules"},{"key":"B108","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-025-00779-x","article-title":"Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies","volume":"13","author":"Liu","year":"","journal-title":"Biomark. Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13148-021-01046-0","article-title":"Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy","volume":"13","author":"Lodewijk","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"B110","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41590-024-01746-8","article-title":"Targeting JMJD1C to selectively disrupt tumor Treg cell fitness enhances antitumor immunity","volume":"25","author":"Long","year":"2024","journal-title":"Nat. Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.immuni.2020.06.011","article-title":"A genome-wide CRISPR screen reveals a role for the non-canonical nucleosome-remodeling BAF complex in Foxp3 expression and regulatory T cell function","volume":"53","author":"Loo","year":"2020","journal-title":"Immunity"},{"key":"B112","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.immuni.2008.11.010","article-title":"Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein","volume":"30","author":"Lu","year":"2009","journal-title":"Immunity"},{"key":"B113","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol. Cancer"},{"key":"B114","doi-asserted-by":"publisher","first-page":"6985031","DOI":"10.1155\/2018\/6985031","article-title":"STAT5 and TET2 cooperate to regulate FOXP3-TSDR demethylation in CD4+ T cells of patients with colorectal cancer","volume":"2018","author":"Ma","year":"2018","journal-title":"J. Immunol. Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1228331","DOI":"10.3389\/fimmu.2023.1228331","article-title":"Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy","volume":"14","author":"Ma","year":"2023","journal-title":"Front. Immunol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/genes10110927","article-title":"The critical role of hypoxic microenvironment and epigenetic deregulation in esophageal cancer radioresistance","volume":"10","author":"Macedo-Silva","year":"2019","journal-title":"Genes"},{"key":"B117","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molimm.2024.08.004","article-title":"Acidity induces durable enhancement of Treg cell suppressive functions for tumor immune evasion","volume":"174","author":"Mani","year":"2024","journal-title":"Mol. Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1038\/ncomms9152","article-title":"Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation","volume":"6","author":"Manna","year":"2015","journal-title":"Nat. Commun."},{"key":"B119","doi-asserted-by":"publisher","first-page":"eaav1741","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Sci. (New York, N.Y.)"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e005442","DOI":"10.1136\/jitc-2022-005442","article-title":"Combining precision oncology and immunotherapy by targeting the MALT1 protease","volume":"10","author":"Mempel","year":"2022","journal-title":"J. For Immunother. Cancer"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jhep.2023.08.024","article-title":"Immunosuppressive CD10+ALPL+ neutrophils promote resistance to anti-PD-1 therapy in HCC by mediating irreversible exhaustion of T cells","volume":"79","author":"Meng","year":"2023","journal-title":"J. Hepatology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"110060","DOI":"10.1016\/j.isci.2024.110060","article-title":"Patient-specific colorectal-cancer-associated fibroblasts modulate tumor microenvironment mechanics","volume":"27","author":"Micalet","year":"2024","journal-title":"IScience"},{"key":"B123","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41590-025-02137-3","article-title":"IL-10 targets IRF transcription factors to suppress IFN and inflammatory response genes by epigenetic mechanisms","volume":"26","author":"Mishra","year":"2025","journal-title":"Nat. Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell."},{"key":"B125","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1073\/pnas.1312717110","article-title":"Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcriptional regulation","volume":"111","author":"Morikawa","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B126","doi-asserted-by":"publisher","first-page":"155992","DOI":"10.1016\/j.prp.2025.155992","article-title":"EZH2 regulatory roles in cancer immunity and immunotherapy","volume":"270","author":"Mortezaee","year":"2025","journal-title":"Pathology, Res. Pract."},{"key":"B127","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41392-021-00598-0","article-title":"Lactate-avid regulatory T cells: metabolic plasticity controls immunosuppression in tumour microenvironment","volume":"6","author":"Multhoff","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B128","doi-asserted-by":"publisher","first-page":"100959","DOI":"10.1016\/j.jhepr.2023.100959","article-title":"Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers","volume":"6","author":"Myojin","year":"2023","journal-title":"JHEP Rep. Innovation Hepatology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ni.3345","article-title":"Apoptotic epithelial cells control the abundance of Treg cells at barrier surfaces","volume":"17","author":"Nakahashi-Oda","year":"2016","journal-title":"Nat. Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/08820139.2014.938165","article-title":"Peripheral whole blood FOXP3 TSDR methylation: a potential marker in severity assessment of autoimmune diseases and chronic infections","volume":"44","author":"Ngalamika","year":"2015","journal-title":"Immunol. Investig."},{"key":"B131","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1158\/1078-0432.CCR-14-0830","article-title":"Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive\/refractory mycosis fungoides and S\u00e9zary syndrome","volume":"21","author":"Ni","year":"2014","journal-title":"Clin. Cancer Res. An Official J. Am. Assoc. For Cancer Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-020-0129-7","article-title":"Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+\u03b3\u03b41 Treg cells","volume":"5","author":"Ni","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.ccell.2023.11.001","article-title":"Therapeutic targeting of EP300\/CBP by bromodomain inhibition in hematologic malignancies","volume":"41","author":"Nicosia","year":"2023","journal-title":"Cancer Cell."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41590-024-01912-y","article-title":"Targeting p97-Npl4 interaction inhibits tumor Treg cell development to enhance tumor immunity","volume":"25","author":"Nie","year":"2024","journal-title":"Nat. Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00262-011-1025-3","article-title":"Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction","volume":"60","author":"Niu","year":"2011","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e004605","DOI":"10.1136\/jitc-2022-004605","article-title":"Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells","volume":"10","author":"Noyes","year":"2022","journal-title":"J. For Immunother. Cancer"},{"key":"B137","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nri2204","article-title":"BLIMP1 guides the fate of effector B and T cells","volume":"7","author":"Nutt","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell. Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.4049\/jimmunol.0901247","article-title":"A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments","volume":"183","author":"Ohta","year":"2009","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41590-021-01008-x","article-title":"Restoring control over autoimmunity by inducing Foxp3","volume":"22","author":"Ono","year":"2021","journal-title":"Nat. Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1158\/2326-6066.Cir-18-0066","article-title":"Treg fragility: a prerequisite for effective antitumor immunity?","volume":"6","author":"Overacre-Delgoffe","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-\u03b3 drives treg fragility to promote anti-tumor immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell."},{"key":"B143","doi-asserted-by":"publisher","first-page":"E6546","DOI":"10.1073\/pnas.1720113115","article-title":"Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth","volume":"115","author":"Pacella","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B144","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41423-020-0505-9","article-title":"Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment","volume":"17","author":"Pan","year":"2020","journal-title":"Cell. and Mol. Immunol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"2073010","DOI":"10.1080\/2162402X.2022.2073010","article-title":"Combination with toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma","volume":"11","author":"Pan","year":"2022","journal-title":"Oncoimmunology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"114724","DOI":"10.1016\/j.celrep.2024.114724","article-title":"Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation","volume":"43","author":"Peeters","year":"2024","journal-title":"Cell. Rep."},{"key":"B147","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijbiomac.2018.06.033","article-title":"LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448\/IDO","volume":"118","author":"Pei","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1158\/1078-0432.CCR-17-1178","article-title":"Immunomodulation by entinostat in renal cell carcinoma patients receiving high-dose interleukin 2: a multicenter, Single-Arm, phase I\/II trial (NCI-CTEP#7870)","volume":"23","author":"Pili","year":"2017","journal-title":"Clin. Cancer Res. An Official J. Am. Assoc. For Cancer Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.3390\/ijms22137144","article-title":"Regulatory T cells-related genes are under DNA methylation influence","volume":"22","author":"Piotrowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T cells exhibit distinct features in human breast cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity"},{"key":"B151","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12943-019-0992-4","article-title":"Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment","volume":"18","author":"Qu","year":"2019","journal-title":"Mol. Cancer"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1284344","DOI":"10.3389\/fimmu.2023.1284344","article-title":"Histone lactylation regulates cancer progression by reshaping the tumor microenvironment","volume":"14","author":"Qu","year":"2023","journal-title":"Front. Immunol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nri3650","article-title":"FOXP3 and scurfy: how it all began","volume":"14","author":"Ramsdell","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3390\/ijms21051673","article-title":"The fate of Th17 cells is shaped by epigenetic modifications and remodeled by the tumor microenvironment","volume":"21","author":"Renaude","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol. Rev."},{"key":"B156","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.4049\/jimmunol.177.11.7794","article-title":"Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2","volume":"177","author":"Rolph","year":"2006","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"B157","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cmet.2020.01.006","article-title":"Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming","volume":"31","author":"Roy","year":"2020","journal-title":"Cell. Metab."},{"key":"B158","doi-asserted-by":"publisher","first-page":"101167","DOI":"10.1016\/j.mam.2022.101167","article-title":"Extracellular vesicles in the glioblastoma microenvironment: a diagnostic and therapeutic perspective","volume":"91","author":"Russo","year":"2023","journal-title":"Mol. Aspects Med."},{"key":"B159","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00262-015-1776-3","article-title":"Improving cancer immunotherapy with DNA methyltransferase inhibitors","volume":"65","author":"Saleh","year":"2015","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"B160","doi-asserted-by":"publisher","first-page":"740588","DOI":"10.3389\/fimmu.2022.740588","article-title":"FOXP3\/HAT1 axis controls treg infiltration in the tumor microenvironment by inducing CCR4 expression in breast cancer","volume":"13","author":"Sarkar","year":"2022","journal-title":"Front. Immunol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13148-018-0539-3","article-title":"DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer","volume":"10","author":"Sasidharan Nair","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"B162","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","article-title":"Regulatory T cell development","volume":"38","author":"Savage","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat. Immunol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41423-024-01229-8","article-title":"Glut3 promotes cellular O-GlcNAcylation as a distinctive tumor-supportive feature in Treg cells","volume":"21","author":"Sharma","year":"2024","journal-title":"Cell. and Mol. Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"e30815","DOI":"10.1371\/journal.pone.0030815","article-title":"Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models","volume":"7","author":"Shen","year":"2012","journal-title":"PloS One"},{"key":"B166","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s12016-016-8590-3","article-title":"Epigenetic variability of CD4+CD25+ tregs contributes to the pathogenesis of autoimmune diseases","volume":"52","author":"Shu","year":"2017","journal-title":"Clin. Rev. Allergy and Immunol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1084\/jem.20130579","article-title":"Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma","volume":"210","author":"Simpson","year":"2013","journal-title":"J. Exp. Med."},{"key":"B168","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41417-021-00371-z","article-title":"Protean role of epigenetic mechanisms and their impact in regulating the Tregs in TME","volume":"29","author":"Smiline Girija","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"B169","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijrobp.2015.01.011","article-title":"Combination effect of regulatory T-cell depletion and ionizing radiation in mouse models of lung and colon cancer","volume":"92","author":"Son","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B170","first-page":"200","article-title":"Deciphering the role of host-gut microbiota crosstalk via diverse sources of extracellular vesicles in colorectal cancer","author":"Song","year":"2024"},{"key":"B171","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrm2347","article-title":"Small non-coding RNAs in animal development","volume":"9","author":"Stefani","year":"2008","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1084\/jem.20190550","article-title":"TGF-\u03b2 signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity","volume":"216","author":"Sun","year":"2019","journal-title":"J. Exp. Med."},{"key":"B173","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13046-023-02815-w","article-title":"Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation","volume":"42","author":"Sun","year":"2023","journal-title":"J. Exp. and Clin. Cancer Res. CR"},{"key":"B174","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1186\/s12967-024-05635-4","article-title":"Predictive nomogram of the clinical outcomes of colorectal cancer based on methylated SEPT9 and intratumoral IL-10+ Tregs infiltration","volume":"22","author":"Sun","year":"2024","journal-title":"J. Transl. Med."},{"key":"B175","doi-asserted-by":"publisher","first-page":"13300","DOI":"10.1021\/acsnano.5c00691","article-title":"Biotin receptor-targeting PtIV oxygen carrying prodrug amphiphile for alleviating tumor hypoxia induced immune chemotherapy suppression","volume":"19","author":"Sun","year":"2025","journal-title":"ACS Nano"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e2023739118","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B177","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1158\/1078-0432.CCR-20-4594","article-title":"IFN\u03b1 augments clinical efficacy of regulatory T-cell depletion with denileukin diftitox in ovarian cancer","volume":"27","author":"Thibodeaux","year":"2021","journal-title":"Clin. Cancer Res. An Official J. Am. Assoc. For Cancer Res."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1576781","DOI":"10.3389\/fonc.2025.1576781","article-title":"Advances of HDAC inhibitors in tumor therapy: potential applications through immune modulation","volume":"15","author":"Tian","year":"2025","journal-title":"Front. Oncol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"e2408649121","DOI":"10.1073\/pnas.2408649121","article-title":"MiR-155-targeted IcosL controls tumor rejection","volume":"121","author":"Tili","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B180","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1089\/ars.2017.7262","article-title":"Short and long noncoding RNAs regulate the epigenetic status of cells","volume":"29","author":"Uchida","year":"2018","journal-title":"Antioxidants and Redox Signal."},{"key":"B182","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3390\/cancers13092018","article-title":"Overcoming the immunosuppressive tumor microenvironment in multiple myeloma","volume":"13","author":"Uckun","year":"2021","journal-title":"Cancers"},{"key":"B183","doi-asserted-by":"publisher","first-page":"eabn8097","DOI":"10.1126\/sciimmunol.abn8097","article-title":"Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation","volume":"7","author":"van Pul","year":"2022","journal-title":"Sci. Immunol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"9928","DOI":"10.1021\/acs.jmedchem.6b01315","article-title":"Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a potent and selective inhibitor of histone methyltransferase EZH2, suitable for phase I clinical trials for B-Cell lymphomas","volume":"59","author":"Vaswani","year":"2016","journal-title":"J. Med. Chem."},{"key":"B185","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2013.06.006","article-title":"Treg and CTLA-4: two intertwining pathways to immune tolerance","volume":"45","author":"Walker","year":"2013","journal-title":"J. Autoimmun."},{"key":"B188","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11523-011-0182-9","article-title":"The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN","volume":"6","author":"Wang","year":"2011","journal-title":"Target. Oncol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/2326-6066.CIR-15-0073","article-title":"Decitabine enhances lymphocyte migration and function and synergizes with CTLA-4 blockade in a murine ovarian cancer model","volume":"3","author":"Wang","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"B190","first-page":"8389","article-title":"Tumor cells induced-M2 macrophage favors accumulation of Treg in nasopharyngeal carcinoma","volume":"10","author":"Wang","year":"2017","journal-title":"Int. J. Clin. Exp. Pathology"},{"key":"B191","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1016\/j.celrep.2018.05.050","article-title":"Targeting EZH2 reprograms intratumoral regulatory T cells to enhance cancer immunity","volume":"23","author":"Wang","year":"","journal-title":"Cell. Rep."},{"key":"B192","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-018-0913-y","article-title":"Effects of tumor metabolic microenvironment on regulatory T cells","volume":"17","author":"Wang","year":"","journal-title":"Mol. Cancer"},{"key":"B193","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41586-023-05780-8","article-title":"H3K4me3 regulates RNA polymerase II promoter-proximal pause-release","volume":"615","author":"Wang","year":"","journal-title":"Nature"},{"key":"B194","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/imm.13520","article-title":"Human FOXP3 and tumour microenvironment","volume":"168","author":"Wang","year":"","journal-title":"Immunology"},{"key":"B195","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"","journal-title":"NPJ Precis. Oncol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"114222","DOI":"10.1016\/j.celrep.2024.114222","article-title":"The histone lysine methyltransferase MLL1 regulates the activation and functional specialization of regulatory T cells","volume":"43","author":"Wang","year":"","journal-title":"Cell. Rep."},{"key":"B197","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41573-024-01089-x","article-title":"Harnessing the biology of regulatory T cells to treat disease","volume":"24","author":"Wardell","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"B198","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.it.2019.03.005","article-title":"PD-1 tumor suppressor signaling in T cell lymphomas","volume":"40","author":"Wartewig","year":"2019","journal-title":"Trends Immunol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B200","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00018-020-03581-0","article-title":"Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resistance","volume":"78","author":"Wei","year":"2021","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"B201","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.it.2025.01.001","article-title":"CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells","volume":"46","author":"Wen","year":"2025","journal-title":"Trends Immunol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41590-019-0351-z","article-title":"Regulatory T cell adaptation in the intestine and skin","volume":"20","author":"Whibley","year":"2019","journal-title":"Nat. Immunol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1158\/2326-6066.CIR-18-0056","article-title":"A2AR antagonism with CPI-444 induces antitumor responses and augments efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in preclinical models","volume":"6","author":"Willingham","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"B204","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. and Oncol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.3522","article-title":"Affinity for self antigen selects Treg cells with distinct functional properties","volume":"17","author":"Wyss","year":"2016","journal-title":"Nat. Immunol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1002\/ijc.29979","article-title":"HDAC5 controls the functions of Foxp3(+) T-regulatory and CD8(+) T cells","volume":"138","author":"Xiao","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B207","doi-asserted-by":"publisher","first-page":"624725","DOI":"10.3389\/fimmu.2021.624725","article-title":"Tumor immune microenvironment and its related miRNAs in tumor progression","volume":"12","author":"Xing","year":"2021","journal-title":"Front. Immunol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell."},{"key":"B209","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature23475","article-title":"Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism","volume":"548","author":"Xu","year":"2017","journal-title":"Nature"},{"key":"B210","doi-asserted-by":"publisher","first-page":"e010040","DOI":"10.1136\/jitc-2024-010040","article-title":"Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion","volume":"12","author":"Xue","year":"2024","journal-title":"J. For Immunother. Cancer"},{"key":"B211","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11427-018-9428-9","article-title":"The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy","volume":"62","author":"Yan","year":"2019","journal-title":"Sci. China. Life Sci."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/s12276-023-01080-3","article-title":"Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. and Mol. Med."},{"key":"B213","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B214","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/414652a","article-title":"The AAA ATPase Cdc48\/p97 and its partners transport proteins from the ER into the cytosol","volume":"414","author":"Ye","year":"2001","journal-title":"Nature"},{"key":"B215","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.scib.2018.05.028","article-title":"Identification and functional analysis of heterogeneous FOXP3+ Treg cell subpopulations in human pancreatic ductal adenocarcinoma","volume":"63","author":"Yi","year":"2018","journal-title":"Sci. Bull."},{"key":"B216","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1097\/CM9.0000000000000517","article-title":"Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating Helios levels","volume":"132","author":"Yu","year":"","journal-title":"Chin. Med. J."},{"key":"B217","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.omtn.2019.05.027","article-title":"Long non-coding RNA FENDRR acts as a miR-423-5p sponge to suppress the treg-mediated immune escape of hepatocellular carcinoma cells","volume":"17","author":"Yu","year":"","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1126\/science.355.6332.1386-l","article-title":"Effects of the tumor microenvironment","volume":"355","author":"Zahn","year":"2017","journal-title":"Sci. (New York, N.Y.)"},{"key":"B219","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"","journal-title":"Nature"},{"key":"B220","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41419-019-1435-2","article-title":"Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer","volume":"10","author":"Zhang","year":"","journal-title":"Cell. Death and Dis."},{"key":"B221","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1038\/s41467-020-20089-0","article-title":"Coupling of H3K27me3 recognition with transcriptional repression through the BAH-PHD-CPL2 complex in Arabidopsis","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"B222","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2024.10.010","article-title":"Biomaterials to regulate tumor extracellular matrix in immunotherapy","volume":"376","author":"Zhang","year":"2024","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/2159-8290.CD-19-1352","article-title":"Chromatin regulator CHD1 remodels the immunosuppressive tumor microenvironment in PTEN-deficient prostate cancer","volume":"10","author":"Zhao","year":"2020","journal-title":"Cancer Discov."},{"key":"B224","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.1016\/j.apsb.2025.10.030","article-title":"LSD1 inhibition sensitizes anti-PD1 blockade immunotherapy by inhibiting the long-range attack of tumor-derived extracellular vesicles","volume":"15","author":"Zhao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"B225","doi-asserted-by":"publisher","first-page":"217587","DOI":"10.1016\/j.canlet.2025.217587","article-title":"Epigenetic modification and tumor immunity: unraveling the interplay with the tumor microenvironment and its therapeutic vulnerability and implications","volume":"616","author":"Zheng","year":"2025","journal-title":"Cancer Lett."},{"key":"B226","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.4049\/jimmunol.1202993","article-title":"miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant","volume":"190","author":"Zhou","year":"2013","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"B227","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/j.celrep.2016.08.032","article-title":"BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression","volume":"16","author":"Zhu","year":"2016","journal-title":"Cell. Rep."},{"key":"B228","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1021\/acs.jmedchem.2c01860","article-title":"Discovery of pyridinone derivatives as potent, selective, and orally bioavailable adenosine A2A receptor antagonists for cancer immunotherapy","volume":"66","author":"Zhu","year":"2023","journal-title":"J. Med. Chem."},{"key":"B229","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-024-01633-x","article-title":"The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications","volume":"16","author":"Zhu","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"B230","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12026-014-8616-y","article-title":"FOXP3+ tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer","volume":"61","author":"Zhuo","year":"2015","journal-title":"Immunol. Res."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1787421\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:10:21Z","timestamp":1774563021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1787421\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":230,"alternative-id":["10.3389\/fgene.2026.1787421"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1787421","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1787421"}}